ISSX 2025 - 14th International Meeting

Cloud Gate sculpture in Chicago’s Millennium Park reflecting the skyline, home of the 2025 ISSX International meeting with a focus on DMPK and Radiolabelling.

Join Pharmaron from September 21st to 24th at ISSX 2025

Pharmaron will be exhibiting at the 14th ISSX International Meeting from September 21–24, 2025, in Chicago, IL. at the Hilton Chicago. Pharmaron offers an end-to-end solution from discovery through clinical development. Our comprehensive expertise in Carbon-14 and tritium radiolabelling for ADME studies, including QWBA tissue distribution and in vitro cross-species comparative metabolism data, provides critical insights for selecting toxicology species, predicting compound distribution and metabolism, and bridging non-clinical and clinical studies. Early-stage screening and regulatory-compliant toxicology studies seamlessly transition from lead optimization to IND-enabling studies.

Please schedule a meeting with our team below to discuss your requirements and challenges related to hit identification, lead optimization, candidate selection, formulation, in vitro /in vivo profiling, DMPK, IND submission, or clinical development.

Our ISSX 2025 Schedule

Exhibit Booth # 307

Exhibit Hours

  • Monday, September 22 – 9:30 a.m. – 7:30 p.m.
  • Tuesday, September 23 – 9:30 a.m. – 7:30 p.m.
  • Wednesday, September 24 – 9:30 a.m. – 2:30 p.m.
Scientist with light brown hair and leopard-print top, smiling in front of a neutral grey background with a dark blue oval frame.
Marie Croft
Scientific Director
Radiolabelled Sciences
Headshot of a brunette woman in a red blazer smiling over a grey background in a blue oval.
Brittany Timmons
Associate Director, Strategic Partnerships
Bioanalysis
Scientist wearing glasses and a striped shirt with a name badge, framed in an oval border against a light gray background.
Guru Valicherla
Senior Scientist II
Regulatory In Vitro ADME
Male scientist with short brown hair wearing a light blue collared shirt, smiling slightly, framed in a blue oval.
Igor Mezine
Principal Research Fellow
Smiling scientist with straight black hair, wearing a white blouse and a silver flower necklace, framed in a blue oval.
Chunyan Hun
Executive Director, DMPK
Professional headshot of a smiling man with short-cropped hair and glasses, wearing a navy blazer and light blue shirt, framed within a circular border.
Barry Jones
Chief Scientist ,Global DMPK
Scientist with glasses wearing a black blazer and yellow floral blouse, framed in an oval with a blue border.
Libo Xu
Senior Director, Business Development
Smiling business development person with long brown hair, wearing a white blouse and earrings, framed in an oval with a blue border.
Jillian Delehoy
DP&C Business Development
Smiling scientist in a blue blouse wearing an orange conference lanyard, framed in a dark blue oval on a light gray background.
Jessica Richardson
Senior Programme Manager
Metabolism

With presentations scheduled every day of the show, you have several opportunities to engage with our experts, explore how their research applies to your programs, and connect in person. Our advanced capabilities and depth of expertise are designed to help accelerate your success, while keeping us, and our partners, at the forefront of the industry.

Talks and Posters

Monday, Sept. 22 Talks and Posters

Talk:

1:45 PM in the Exhibit Hall Presentation Area

  • Marie Croft, Scientific Director of Radiolabelled Sciences, Presenting: Accelerator Mass Spectrometry in Drug Development: Clinical Applications and Technological Advances

    Accelerator Mass Spectrometry (AMS) is increasingly used in drug development to detect low levels of radiolabeled (14C) compounds, especially in clinical studies such as human absorption, metabolism, and excretion (hAME) and absolute bioavailability (hABA). Initially adopted for drugs with long half-lives or low exposure, AMS has gained broader acceptance following industry recommendations and FDA guidance. It is particularly valuable when conventional methods like liquid scintillation counting lack sensitivity, such as in studies with low plasma concentrations of parent drugs or metabolites.

    In this presentation, we demonstrate the clinical applications and technological advancements of AMS, including its evolution from early graphite-based systems to the latest low-energy Ionplus LEA platforms now operational across Pharmaron’s global network.

Posters in Continental B/C :

Tuesday, Sept. 23 Posters in Continental B/C

12:30–1:30 PM

1:30–2:30 PM

Wednesday, Sept. 24 Posters in Continental B/C

1:30–2:30 PM

Our scientists are eager to discuss how their findings can help advance your programs.

About the ISSX

The 14th International ISSX Meeting will focus on emerging technologies and innovations in drug metabolism, pharmacokinetics, and drug transport research. The event will feature expert-led short courses, scientific debates, poster presentations, and state-of-the-art exhibits, making it an essential gathering for researchers and industry leaders.

For more information and event registration, please visit the ISSX website.

Complete this form to Request a Meeting

Learn More About Pharmaron‘s Services